Metformin and Chemoprevention: Potential for Heart-Healthy Targeting of Biologically Aggressive Breast Cancer

Currently, tamoxifen is the only drug approved for reduction of breast cancer risk in premenopausal women. The significant cardiovascular side effects of tamoxifen, coupled with lack of a survival benefit, potential for genotoxicity, and failure to provide a significant risk-reduction for estrogen r...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Front Public Health
Autores principales: Jones, Veronica C., Dietze, Eric C., Jovanovic-Talisman, Tijana, McCune, Jeannine S., Seewaldt, Victoria L.
Formato: Artigo
Lenguaje:Inglês
Publicado: Frontiers Media S.A. 2020
Materias:
Public Health
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7658387/
https://ncbi.nlm.nih.gov/pubmed/33194937
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fpubh.2020.509714
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares